✦ LIBER ✦

Cell dose and graft versus host disease (GVHD) affect survival in allogeneic peripheral blood stem cell transplantation (alloPBSCT) following non-myeloablative (NM) conditioning: A single center experience

✍ Scribed by J.L. Johnson; M. Vusirikala; W. Chinratanalab; S. Brandt; Y. Shyr; B. Shakhtour; A. Kassim; M. Jagasia; D. Morgan; K. Ruffner; R. Stein; J. Greer; F. Schuening; S. Goodman

Book ID: 116278585
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 57 KB
Volume: 12
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2005.11.142

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

233: CD34 dose and chronic graft versus

233: CD34 dose and chronic graft versus host disease (cGVHD) affect survival in allogeneic peripheral blood stem cell transplantation (alloPBSCT) following non-myeloablative (NM) conditioning: The Vanderbilt University/Nashville VA SCT program experience

✍ G. Ewing; J. Giglia; M. Vusirikala; F. Ye; Y. Shyr; W. Chinratanalab; K. Ruffner 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Incidence Of Graft-Versus-Host Disease (

Incidence Of Graft-Versus-Host Disease (GVHD) In Patients With Allogeneic Peripheral Hematopoietic Stem Cell Transplantation After A Non-Myeloablative Conditioning

✍ O.G. Cantú; H. Gutiérrez; G. Ruiz; C. Mancías; S.A. Martínez; O. González; J.C. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 57 KB

High Rates of Non-Relapse Mortality and

High Rates of Non-Relapse Mortality and Graft-Versus-Host Disease in Patient Undergoing Allogeneic Stem Cell Transplantation (ASCT) Following Non-Myeloablative (NMA) Conditioning With TLI/ATG

✍ A.S. Kanate; L. Chaudhary; A. Cumpston; S. Leadmon; P. Bunner; D. Bulian; L. Gib 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 60 KB